Reuters: Global Markets: Biotech company Intrexon shares surge 38 percent in debut

Reuters: Global Markets Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Biotech company Intrexon shares surge 38 percent in debut Aug 8th 2013, 13:56 Thu Aug 8, 2013 9:56am EDT (Reuters) - Biotechnology company Intrexon Corp's XON.N shares rose as much as 38 percent in their market debut, valuing the company at more than $2 billion. Intrexon raised $160 million after its initial public offering of 10 million shares was priced at $16 each, at the high end of the expected range. The company's shares were trading at $22.36 on the New York Stock Exchange. About 1.9 million shares had changed hands at 0952 ET. The stock was the top percentage gainer on the exchange.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions